Australian Clinical Labs Ltd ACL
Trading Information
- Previous Close Price
- A$2.46
- Day Range
- A$2.45–2.55
- 52-Week Range
- A$2.26–3.69
- Bid/Ask
- A$2.45 / A$2.47
- Market Cap
- A$494.49 Mil
- Volume/Avg
- 144,588 / 526,605
Key Statistics
- Price/Earnings (Normalized)
- 23.59
- Price/Sales
- 0.73
- Dividend Yield (Trailing)
- 4.06%
- Dividend Yield (Forward)
- 4.06%
- Total Yield
- 4.19%
Company Profile
Australian Clinical Labs, or ACL, is Australia’s third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.clinicallabs.com.au
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Tblmvydjk | Ssbr | $209.3 Bil | |
DHR
| Danaher Corp | Jzwdkcjxrj | Zhsqln | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Ndmflcmt | Rhkxhyy | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Hzdhxrxs | Kqqxn | $41.5 Bil | |
A
| Agilent Technologies Inc | Scrqsygqw | Tjkb | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Ngypfnjmzb | Ffxmhq | $26.5 Bil | |
ICLR
| Icon PLC | Lglzjcby | Rnsmnp | $24.8 Bil | |
ILMN
| Illumina Inc | Rhhhtcpm | Ncfnkjl | $19.5 Bil | |
WAT
| Waters Corp | Nggjmmhzk | Rtn | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Sldzzhpvr | Srlbmw | $16.7 Bil |